Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System
Author:
Publisher
Springer International Publishing
Link
https://link.springer.com/content/pdf/10.1007/16833_2024_286
Reference157 articles.
1. Akazawa T, Kwatra SG, Goldsmith LE, Richardson MD, Cox EA, Sampson JH, Kwatra MM (2009) A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas. J Neurochem 109:1079–1086. https://doi.org/10.1111/j.1471-4159.2009.06032.x
2. Akbari S, Assaran Darban R, Javid H, Esparham A, Hashemy SI (2023) The anti-tumoral role of hesperidin and aprepitant on prostate cancer cells through redox modifications. Naunyn Schmiedeberg’s Arch Pharmacol 396:3559–3567. https://doi.org/10.1007/s00210-023-02551-0
3. AlAlikhan A, Ghahremanloo A, Javid H, Ebrahimi S, Hashemy SI (2022) The effect of blocking neurokinin-1 receptor by aprepitant on the inflammatory and apoptosis pathways in human ovarian cancer cells. Cell Biochem Biophys 80:819–827. https://doi.org/10.1007/s12013-022-01100-5
4. Alsaeed MA, Ebrahimi S, Alalikhan A, Hashemi SF (2022) The potential in vitro inhibitory effects of neurokinin-1 receptor (NK-1R) antagonist, aprepitant, in osteosarcoma cell migration and metastasis. Biomed Res Int 2022:8082608. https://doi.org/10.1155/2022/8082608
5. Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25:366–428. https://doi.org/10.1016/S1043-9471(05)80049-7
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3